Back to rankings
Goodwin

Goodwin

More information

United States • Intellectual property

2

Patents: litigation (full coverage)

Goodwin‘s patent litigation team boasts technical expertise as well as consistently strong performance before the PTAB; it is particularly visible in the life sciences sector. A significant share of the firm’s bench holds advanced STEM degrees and is able to advise on highly-technical patent disputes. The practice group is also active in tech patent litigation, representing companies in semiconductors, consumer electronics and software. Elaine Blais, a Boston-based trial attorney recognised for her extensive experience in the life sciences litigation, co-chairs the practice group. Another co-chair, Brett Schuman, operates out of San Francisco and is well-regarded for his patent infringement litigation in the telecom sector.
Legal 500 Editorial commentary

Accolades

Client satisfaction: Lawyer & team quality

Testimonials

Collated independently by Legal 500 research team.

  • 'Goodwin has a deep bench of experienced, sophisticated pharmaceutical patent litigators. They are one of the few firms that I trust with "bet the company" matters.'
  •  

Work highlights

Achieved a landmark victory for Sandoz, dismantling Regeneron’s patent barriers and securing early market entry for its Eylea® biosimilar (Enzeevu)—breaking open a $6.2 billion market and expanding patient access to sight-saving therapies for age-related macular degeneration.
Secured a sweeping win for Microchip Technology, invalidating multiple patents through PTAB victories and Federal Circuit appeals, and achieving additional favorable rulings in district court before reaching a confidential settlement—a result that underscores Goodwin’s strength in multi-forum semiconductor patent defense.
Secured a decisive trial victory for Fresenius Kabi, eVenus, and Jiangsu Hengrui, invalidating Pacira’s last EXPAREL® patent and clearing the way for generic entry, reinforcing Goodwin’s strength in defeating patent gamesmanship in high-stakes pharma litigation.
Practice head

Elaine Blais; Brett Schuman

Comparative Guides